ArticleScientific reports2019

Cancer cell killing by target antigen engagement with engineered complementary intracellular antibody single domains fused to pro-caspase3.

Jennifer S Chambers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.